Log in to save to my catalogue

Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glio...

Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5984485

Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma

About this item

Full title

Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2018-05, Vol.115 (22), p.E5086-E5095

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Competitive BET bromodomain inhibitors (BBIs) targeting BET proteins (BRD2, BRD3, BRD4, and BRDT) show promising preclinical activities against brain cancers. However, the BET protein-dependent glioblastoma (GBM)-promoting transcriptional network remains elusive. Here, with mechanistic exploration of a next-generation chemical degrader of BET prote...

Alternative Titles

Full title

Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5984485

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5984485

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1712363115

How to access this item